A cost-minimization analysis of intracervical prostaglandin E2 for cervical ripening in an outpatient versus inpatient setting

Clinical Therapeutics

Volumn 18, Issue 4, 1996, Pages 747-756

  Farmer, Kevin C ^a,c   Schwartz III, William J ^b   Rayburn, William F ^b   Turnbull, Gayla ^b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; PROSTAGLANDIN E2;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; FEMALE; FETUS MONITORING; GEL; GESTATIONAL AGE; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; LABOR INDUCTION; MULTIPARA; OUTPATIENT; PHARMACEUTICS; PHARMACOECONOMICS; PRIMIGRAVIDA; TOPICAL DRUG ADMINISTRATION; UTERINE CERVIX RIPENING;

EID: 0029746648     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80224-4     Document Type: Article

References (24)

1. Thiery M. Preinduction cervical ripening. In: Wynn RM, ed. Obstetrics and Gynecology Annual. Norwalk, Conn: Appleton-Century-Crofts; 1983:103-146.
2. Clinch J. Induction of labor: A six-year review. Br J Obstet Gynaecol. 1979;86: 340-342.
3. 2. Gynecol Obstet Invest. 1983;15:291-299.
4. 2 gel for cervical ripening and induction of labor: A critical analysis. Am J Obstet Gynecol. 1989;160:529-534.
5. Kierse MJ. Prostaglandins in preinduction cervical ripening: Meta-analysis of worldwide clinical experience. J Reprod Med. 1993;38(Suppl 1):89-100.
6. 2 (Prepidil) gel. Am J Obstet Gynecol. 1985;153:268-271.
7. 2 intracervical gel. Am J Perinatol. 1985;2:305-310.
8. 2 (Prepidil) gel. J Perinatol. 1987;7:189-193.
9. 2 gel for cervical ripening and labour induction: A multicentre placebo-controlled trial. Can Med Assoc J. 1991;145:1249-1254.
10. 2 gel: A placebo-controlled study. Am J Obstet Gynecol. 1987; 156:336-340.
11. 2 for cervical ripening and induction of labor. Am J Obstet Gynecol. 1994;171:1087-1091.
12. Facts and Comparisons®. St. Louis: Facts and Comparisons, Inc; 1995:118n-188q.
13. 2 gel. Safety for outpatient cervical ripening before induction of labor. J Reprod Med. 1992;37: 713-716.
14. Dyson DC, Miller PD, Armstrong MA. Management of prolonged pregnancy: Induction of labor versus antepartum fetal testing. Am J Obstet Gynecol. 1987;156: 928-934.
15. 2 gel in uncomplicated postdate pregnancies. Am J Obstet Gynecol. 1988; 158:1417-1423.
16. 2 suppositories in post-date pregnancies: A double-blind, randomized, placebo-controlled study. Obstet Gynecol. 1994;84:807-810.
17. 2: A randomized, double-blind placebo-controlled trial. Am J Obstet Gynecol. 1995;173:1855-1859.
18. Sawai SK, O'Brien WF. Outpatient cervical ripening. Clin Obstet Gynecol. 1995; 38:301-309.
19. Bishop EH. Pelvic scoring for elective induction. Obstet Gynecol. 1964;24:266-271.
20. American College of Obstetricians and Gynecologists. Induction of labor. ACOG technical bulletin. No. 217: Washington, DC: American College of Obstetricians and Gynecologists; December 1995.
21. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. NEJM. 1977;296: 716-721.
22. Robinson R. Costs and cost-minimisation analysis. BMJ. 1993;307:726-728.
23. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford Medical Publications; 1987.
24. Eddy DM. Cost-effectiveness analysis: Is it up to the task? JAMA. 1992;267: 3342-3348.